Abstract :

Vaccine hesitancy is defined by the World Health Organization (WHO) as a behavior influenced by several factors, including issues of confidence (do not trust vaccine or provider), complacency (do not perceive a need for a vaccine, do not value the vaccine), and convenience (do not perceive a need for a vaccine, do not value the vaccine) (access). Muslim consumers are becoming increasingly aware of halal medications in addition to food products. They’re starting to notice the negative consequences of product development, testing, and production, all of which may deviate from halal standards. As a result of this confusion, the general public is beginning to question the sources of their medicinal items.

Conservative Muslims may refuse vaccinations due to worries that some vaccines were obtained from the contents of pigs or porcine, which Muslims are prohibited from eating. Today, a quarter of the inhabitants of the world are Muslims. This figure is expected to grow by 35% over the next two decades, leaping from 1.6 billion to 2.2 billion by 2030. By 2021, the worldwide halal pharmaceutical industry will be worth USD 132 billion. Based on data from the Directorate General of Population and Civil Registration of the Ministry of Home Affairs, the total population of Indonesia is 272.23 million in June 2021. Of this number, 236.53 million people (86.88%) are Muslims.

To turn this hesitancy into an opportunity, XYZ Pharmaceutical plans to build a manufacturing plant for halal vaccines. In this research, the vaccines that will be produced by XYZ are ACYW135 Meningococcal Polysaccharide Vaccine, ACYW135 Meningococcal Conjugate Vaccine, 13 Valent Pneumococcal Polysaccharide Vaccine, and 23 Valent Pneumococcal Conjugate Vaccine. These vaccines are selected due to their close association with halal vaccines for the use case of Indonesian vaccine hesitancy. The objective of this study is to assess the feasibility of the halal vaccine manufacturing plant project through financial methods emphasizing capital budgeting technique, internal study, and market analysis. The result of this study shows that the development of the XYZ halal vaccine manufacturing plant is financially feasible due to the net present value of (USD 81,141,154), internal rate of return of (31.43%), the payback period of 4 years and six months, and the profitability index of (5.06), which in other scenarios testing are all acceptable for this project.

---

Keywords :

Capital Budgeting, Feasibility Study, Halal Vaccine, investment, Pharmaceutical.

---

References :

1. (2021). 2020 Global Vaccine Market Report. Available from

https://www.who.int/immunization/programmes_systems/procurement/mi4a/platform/module2/2020_Global_Vaccine_Market_Report.pdf?ua=1 [Accessed on 24 February 2022]

2. Markets & Markets Report. (2022). Vaccine Market Reports. Available from

https://www.marketsandmarkets.com/Market-Reports/vaccine-technologies-market-1155.html [Accessed on 14 February 2022]

3. Bio Farma. (2021). Annual Report 2020. Bio Farma. https://www.biofarma.co.id/id/annual-report [Accessed on 12 February 2022]
4. Khoo, Y. S., Ghani, A. A., Navamukundan, A. A., Jahis, R., & Gamil, A. (2020). Unique product quality considerations in vaccine development, registration and new program implementation in Malaysia. Human vaccines & immunotherapeutics, 16(3), 530-538.
5. Kasri, R. A., Ahsan, A., Widiatmoko, D., & Hati, S. R. H. (2021). Intention to consume halal pharmaceutical products: evidence from Indonesia. Journal of Islamic Marketing.
6. Rothaermel, Frank T.. (2020). Strategic management (5th Edition.). New York: McGraw-Hill Education.
7. Harapan, H., Mudatsir, M., Yufika, A., Nawawi, Y., Wahyuniati, N., Anwar, S., … & Imrie, A. (2019). Community acceptance and willingness-to-pay for a hypothetical Zika vaccine: A cross-sectional study in Indonesia. Vaccine, 37(11), 1398-1406.
8. Corporate Finance Institute. (2022). SWOT Analysis. Available from

https://corporatefinanceinstitute.com/resources/knowledge/strategy/swot-analysis/ [Accessed on 24 January 2022]

9. Ministry of Health of Republic Indonesia. (2020). COVID-19 Acceptance Survey in Indonesia. Available from

https://covid19.go.id/storage/app/media/Hasil%20Kajian/2020/November/vaccine-acceptance-survey-en-12-11-2020final.pdf [Accessed on 24 February 2022]

10. (2020). Meningitis and Spread in Indonesia. Available from

https://databoks.katadata.co.id/datapublish/2020/04/09/meningitis-dan-persebarannya-di-asean#:~:text=Meningitis%20telah%20menjangkit%20di%20berbagai,di%20Asia%20Tenggara%20akibat%20meningitis. [Accessed on 24 February 2022]

11. (2022). Number of Hajj Pilgrims from Indonesia by Province. Available from

https://www.bps.go.id/indikator/indikator/view_data_pub/0000/api_pub/eVp0d2JDQmlzZzRVc2FESkNvZThPdz09/da_04/3 [Accessed on 24 February 2022]

12. Zunt, J. R., Kassebaum, N. J., Blake, N., Glennie, L., Wright, C., Nichols, E., … & Saxena, S. (2018). Global, regional, and national burden of meningitis, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet Neurology, 17(12), 1061-1082.
13. (2020). Total Pilgrims of Indonesia. Available from https://amphuri.org/infografis-total-pilgrims-of-indonesia/ [Accessed on 24 February 2022]
14. (2019). Pneumococcal Vaccine Overview. Available from

https://www.nhs.uk/conditions/vaccinations/pneumococcal-vaccination/ [Accessed on 24 February 2022]

15. (2021). Immunization Schedule of IDAI in 2020. Available from https://www.idai.or.id/tentang-idai/pernyataan-idai/jadwal-imunisasi-idai-2020 [Accessed on 26 February 2022]
16. (2021). Number of Population by Age Group and Gender. Available from

https://www.bps.go.id/indikator/indikator/view_data_pub/0000/api_pub/YW40a21pdTU1cnJxOGt6dm43ZEdoZz09/da_03/1 [Accessed on 26 February 2022]

17. World Bank. (2021). Population Growth of Indonesia. Available from

https://data.worldbank.org/indicator/SP.POP.GROW?locations=ID&most_recent_year_desc=false [Accessed on 26 February 2022]

18. Project Management Institute. (2017). A guide to the Project Management Body of Knowledge (PMBOK guide) (6th ed.). Project Management Institute.
19. Ullah, I., Khan, K. S., Tahir, M. J., Ahmed, A., & Harapan, H. (2021). Myths and conspiracy theories on vaccines and COVID-19: potential effect on global vaccine refusals. Vacunas, 22(2), 93-97
20. Padmawati, R. S., Heywood, A., Sitaresmi, M. N., Atthobari, J., MacIntyre, C. R., Soenarto, Y., & Seale, H. (2019). Religious and community leaders’ acceptance of rotavirus vaccine introduction in Yogyakarta, Indonesia: a qualitative study. BMC Public Health, 19(1), 1-6.
21. Ab Latiff, J., & Zakaria, Z. (2021). The Challenges in Implementation of Halal Vaccine Certification in Malaysia. Journal of Food and Pharmaceutical Sciences, 9(1), 2-2.
22. Khan, Y. H., Mallhi, T. H., Alotaibi, N. H., Alzarea, A. I., Alanazi, A. S., Tanveer, N., & Hashmi, F. K. (2020). Threat of COVID-19 vaccine hesitancy in Pakistan: the need for measures to neutralize misleading narratives. The American journal of tropical medicine and hygiene, 103(2), 603.
23. MacPherson, Y. (2020). What is the world doing about COVID-19 vaccine acceptance?. Journal of health communication, 25(10), 757-760.